June 30, 2026

Myasthenia Gravis (MG): A Managed Care Guide for Emerging Evidence-Based Management Strategies

Myasthenia Gravis (MG): A Managed Care Guide for Emerging Evidence-Based Management Strategies
Myasthenia Gravis (MG): A Managed Care Guide for Emerging Evidence-Based Management Strategies
PayerTalkCE
Myasthenia Gravis (MG): A Managed Care Guide for Emerging Evidence-Based Management Strategies
This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/mg-management. Managed care professionals face unique challenges in optimizing outcomes for patients with MG, a rare, chronic autoimmune neuromuscular disorder characterized by fluctuating muscle weakness and fatigue. The increasing prevalence and complexity of MG, combined with rapid advances in targeted therapies, require updated knowledge and strategic approaches to coverage, management, and equitable access.